SCHEMBL18857026

SCHEMBL18857026

CCOC(=O)C(NC(=O)OCc1ccccc1)C(C)C=O

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSL P07711 5/20 0.54
CTSS P25774 4/20 0.54
CTSB P07858 3/20 0.54
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
RAB9A P51151 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 1/20 0.52
ATM Q13315 1/20 0.51
CTSK P43235 4/20 0.50
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18857025 1.00 CTSL (0.54) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL18856965 0.90 CTSL (0.52) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL17225848 0.89 TRPM8 (0.58) CTSLCTSSCTSBMEN1KMT2A
SCHEMBL24596987 0.88 CTSB (0.59) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL18840086 0.88 CTSL (0.56) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL14595222 0.88 CTSB (0.59) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL18857043 0.86 CTRB1 (0.51) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL27310595 0.85 CYP3A4 (0.69) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL18857016 0.84 CTSL (0.53) CTSLCTSSCTSBCYP3A4CYP2D6
SCHEMBL11449968 0.83 CTRB1 (0.52) CTSLCTSSCTSBRAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017082924-A1 PEPTIDE AND PEPTIDE MIMETIC BINDING ANTAGONISTS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2017-05-18 WO disclosed